altRX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: low-cost compounded GLP-1s with brand-name Zepbound, Wegovy and Ozempic as options
altRX scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
Price checked on altRX’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
PartneraltRX is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money
altRx is an online weight-loss membership offering compounded semaglutide and tirzepatide plus brand-name Zepbound, Wegovy and Ozempic. Compounded plans are listed at $89/mo for semaglutide and $149/mo for tirzepatide, the same price at every dose, while brand-name options run $1,149 to $1,579/mo. Care comes from the OpenLoop Healthcare Partners clinician network, and the site names its four partner pharmacies.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
altRX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Ozempic, Zepbound
- Starting price
- $89/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record; see below
How we scored altRX
Each dimension is scored algorithmically from altRX’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
9.2/10At $89/mo, altRX runs about 50% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.3/10altRX offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
5.2/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
6.0/10altRX's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.8/10altRX provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this altRX review
Last checked October 2026- Confirmed current pricing across 5 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $89–$1,579/mo across 5 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with altRX
We walked altRX’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Choose a medication on altRX's website (compounded GLP-1, compounded GLP-1 + GIP, Zepbound, Wegovy or Ozempic) and click 'Get started'.
- 2The assessment opens with a five-stage progress bar (Start, Preliminary, Health, Details, Eligibility).
- 3The first screen asks for height, current weight and goal weight to calculate BMI.
- Monthly prices are on every product page before you start, and the homepage says the compounded price is the same at every dose.
- The billing cadence and any multi-month plan prices are not shown before the assessment.
- The refund policy makes every payment final; canceling stops future charges only and needs 72 hours' notice before the next bill.
- The provider consult 'may take place via live video or through an asynchronous provider review.'
- The FAQ quotes processing and delivery of about 4-5 business days after a prescription.
- altRx's Trustpilot profile is removed, and the site notes some testimonials are from paid endorsers.
altRX customer support
- Phone
- +1 607-601-6969
- care@altrx.com
GLP-1 medications altRX offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
altRx lists compounded semaglutide at '$89/mo', and its homepage says 'Start for just $89' and 'Same price at every dose.' Billing cadence and any multi-month options are shown only after the health assessment.
altRx lists compounded tirzepatide at '$149/mo'. Billing cadence and any multi-month options are shown only after the health assessment.
altRx lists brand-name Ozempic at '$1149/mo', cash pay.
altRx lists brand-name Zepbound at '$1249/mo', cash pay.
altRx lists brand-name Wegovy at '$1579/mo', cash pay.
Ready to get started?
Plans and promotions change often, so check altRX's current pricing and active discounts before you decide.
What we like
- Low compounded pricing: semaglutide $89/mo and tirzepatide $149/mo, the same at every dose
- Brand-name Zepbound, Wegovy and Ozempic available alongside compounded options
- Names its four partner compounding pharmacies, with addresses and phone numbers
- Says it serves all 50 states, with a provider licensed in your state
- No membership fee and free delivery
- Clinician review can be a live video or an asynchronous review
- LegitScript seal for altRX's website
- 24/7 support with unlimited messaging and check-ins
Watch-outs
- All payments are final: no refund once you pay, except a medical disqualification minus services already used
- Multi-month plans are one purchase and are non-refundable in whole and in part
- You must cancel at least 72 hours before your next billing date to stop the next charge
- altRx's Trustpilot profile has been removed by Trustpilot for breaking its guidelines
- Some testimonials on the site are from paid endorsers
- Billing cadence and any multi-month pricing are shown only after the health assessment
- Brand-name pricing is cash-pay only, so check your insurance first
- Binding individual arbitration with a class-action waiver
altRX: cheap flat-rate compounded GLP-1s, with brand pens on the side
Most telehealth weight-loss companies make you pick a lane. Either they sell low-cost compounded medication, or they write prescriptions for the brand-name pens. altRX does both. It sells compounded semaglutide at $89 a month and compounded tirzepatide at $149 a month, the same price at every dose, plus brand-name Ozempic, Wegovy and Zepbound at cash prices. Mounjaro, which altRX used to list, is no longer on its menu. If you want a low compounded price with a brand option under the same login, altRX is built for that. The drawbacks are a strict all-sales-final refund policy and a Trustpilot profile that Trustpilot itself has removed.
How the pricing works
altRX runs a flat model rather than a membership. There's no monthly platform fee on top of your medication, and the homepage says the price covers the consultation, a custom dosing plan, the medication, free delivery and ongoing clinician support. Because the compounded price doesn't rise as your dose does, the number you start at is the number you keep.
- Compounded semaglutide: $89 a month at every dose, the cheapest way onto the platform.
- Compounded tirzepatide (the GLP-1/GIP dual agonist): $149 a month at every dose.
- Brand-name pens, cash-pay: Ozempic $1,149, Zepbound $1,249 and Wegovy $1,579 a month, roughly in line with U.S. retail list prices.
Both compounded prices sit well below our category median of $179, which makes altRX one of the cheaper compounded options we track. What you can't see up front is the billing cadence. The site shows if you're billed monthly or on a multi-month plan, and what any multi-month plan costs, only after the health assessment. That matters here, because multi-month plans are sold as one purchase and can't be refunded. Shoppers who want those multi-month prices before the assessment will find them at the MEDGm platform, which prints its full month-to-month and prepaid ladder on each product page and also sells a dissolving semaglutide tablet.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Read the refund policy before you pay
altRX's refund policy, updated August 25, 2026, makes every payment final and non-refundable at the time of purchase. Multi-month and bundled plans are non-refundable in whole and in part. You can cancel at any time, but canceling only stops future charges, and the request has to arrive at least 72 hours before your next billing date (the Terms say 48 hours, so give yourself the longer window). The one exception is a medical disqualification, which refunds the unused portion minus the services already provided. The Terms also require binding individual arbitration with a class-action waiver. Shoppers who care most about refund options can compare KairoRx, which says it doesn't charge until a provider approves a plan and refunds cancellations within 14 days if the pharmacy hasn't prepared your order, though it doesn't name its medical group or pharmacies.
Medications, pharmacies and who prescribes
Medical care, including evaluation and prescribing, comes from OpenLoop Healthcare Partners, PC and its affiliated practices, and the platform is operated by OpenLoop Health, Inc. altRX says it is a separate legal entity from OpenLoop. The consult can be a live video visit or an asynchronous provider review, and the site names clinicians including Dr. Ana Lisa Carr and Dr. Kelly Tenbrink. Unlike many compounders, altRX now names its four state-licensed 503A compounding pharmacies: RedRock Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama. That is the same OpenLoop setup and pharmacy set SnagRx and IonicMD use. altRX also publishes the FDA's disclaimer that compounded drugs are not FDA-approved or evaluated for safety, effectiveness or quality.
Trust: one credential, one red flag
altRX's site still serves a LegitScript seal (ID 48475686) issued to that site, a meaningful credential. It says it serves all 50 states with a provider licensed in your state, though it doesn't publish a state list, and it quotes about four to five business days for processing and delivery after a prescription. Support runs through care@altrx.com and a phone line, with unlimited messaging.
The red flag is Trustpilot. altRX's Trustpilot page now reads that the profile has been removed because the business goes against Trustpilot's guidelines. That means there is no independent review pool to check. The homepage also notes that some testimonials are from paid endorsers, and its patient-count and press claims are unverified. See our scoring methodology for how we weigh these signals.
Who should choose altRX, and who should skip it
- Choose it if you want a low flat-rate compounded GLP-1 price for semaglutide or tirzepatide that doesn't rise with your dose.
- Choose it if you'd like brand-name Ozempic, Wegovy or Zepbound available by cash-pay under the same account.
- Skip it (or at least price-check first) if you have commercial insurance that might cover a branded GLP-1, since altRX's brand pricing is cash-pay only.
- Skip it if you want the option of a refund, or if a removed Trustpilot profile is a dealbreaker for you.
The bottom line
altRX now competes mainly on price: $89 compounded semaglutide and $149 compounded tirzepatide at every dose, with named pharmacies, an OpenLoop clinician network and brand pens as a fallback. The reservations are about recourse and reputation. Every payment is final, multi-month plans can't be refunded, and Trustpilot has pulled its profile. If you're comfortable with those terms, start on a single month rather than a multi-month plan, and cancel at least 72 hours before your next bill if it isn't working.
The Bottom Line
altRX scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with altRX?
From $89/mo. See current pricing and start your free consultation.
Alternatives to altRX
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare altRX vs…
altRX scores7.4/10
Side-by-side pricing, medications and scores. Pick a matchup.
altRX vs Amazon One Medical
Amazon One Medical scores 8.5/10

altRX vs Vytora Health
Vytora Health scores 8.4/10

altRX vs CoreAge Rx
CoreAge Rx scores 8.3/10

altRX vs Collective
Collective scores 8.3/10

altRX vs Found
Found scores 8.3/10
altRX vs EverSlim
EverSlim scores 8.3/10
All 45 altRX comparisons
- altRX vs AgelessRx
- altRX vs Belle Health
- altRX vs bmiMD
- altRX vs Bodybuilding Health+
- altRX vs Brightmeds
- altRX vs Direct Meds
- altRX vs DudeMeds
- altRX vs Eden
- altRX vs Embody
- altRX vs Enhance MD
- altRX vs Gala
- altRX vs GobyMeds
- altRX vs HealthRX
- altRX vs HumeCare+
- altRX vs Ivim Health
- altRX vs Live Vital
- altRX vs Lttl
- altRX vs Luvo Health
- altRX vs MadeMed
- altRX vs MangoRx
- altRX vs Maximus
- altRX vs MEDGm
- altRX vs MEDVi
- altRX vs Midi Health
- altRX vs NewSelf
- altRX vs Oak
- altRX vs PlexusDx
- altRX vs Ro
- altRX vs RxSpan MD
- altRX vs Sesame Care
- altRX vs ShedRx
- altRX vs SkinnyRx
- altRX vs SnagRx
- altRX vs Sprout Health
- altRX vs Strut Health
- altRX vs TMates
- altRX vs TrimRx
- altRX vs Wellorithm
- altRX vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
altRX received an FDA warning letter dated June 8, 2026
The letter concerns false & misleading claims/misbranded (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this altRX review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See altRX's current pricing
Plans from $89/mo. Start your free consultation to check eligibility and today's price.